Bruno Lemarchant, Cristina Birzu, Louis Couzyn, Stéphanie Rogeau, Delphine Leclercq, Hélène Zéphir, Dimitri Psimaras
{"title":"Anti-GAD Antibodies as an Etiology of Cerebral Cortical Encephalitis: 2 Case Reports","authors":"Bruno Lemarchant, Cristina Birzu, Louis Couzyn, Stéphanie Rogeau, Delphine Leclercq, Hélène Zéphir, Dimitri Psimaras","doi":"10.1111/ene.70096","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Cerebral cortical encephalitis (CCE) has been recently described as an entity associated with anti-MOG antibodies and, in some cases, of anti-GABA<sub>A</sub>R encephalitis. No clear association with other antibodies has been reported to date. We describe two cases of patients presenting clinical and radiological features of diffuse cortical encephalitis associated with anti-GAD antibodies.</p>\n </section>\n \n <section>\n \n <h3> Method</h3>\n \n <p>In two patients with CCE, screening for the presence of anti-GAD and other antibodies was performed, along with a complete workup for alternative diagnoses.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Two patients showing clinical and radiological features of CCE were tested positive for anti-GAD antibodies. MRI scan revealed multiple bilateral areas of cortico-subcortical FLAIR hyperintensities. They were both tested negative for anti-MOG, anti-NMDAr, and anti-GABA<sub>A</sub>R antibodies. An ovarian teratoma was discovered in patient 1. Clinical and radiological evolution was favorable in both patients after cumulated therapies in the acute phase.</p>\n </section>\n \n <section>\n \n <h3> Discussion</h3>\n \n <p>CCE could be a new manifestation of anti-GAD antibodies, with distinct features compared to anti-MOG antibodies related to CCE. We recommend screening for anti-GAD antibodies in the context of CCE, especially in case of atypical features for MOG antibodies-associated disease (MOGAD).</p>\n </section>\n </div>","PeriodicalId":11954,"journal":{"name":"European Journal of Neurology","volume":"32 3","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ene.70096","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Neurology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ene.70096","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Cerebral cortical encephalitis (CCE) has been recently described as an entity associated with anti-MOG antibodies and, in some cases, of anti-GABAAR encephalitis. No clear association with other antibodies has been reported to date. We describe two cases of patients presenting clinical and radiological features of diffuse cortical encephalitis associated with anti-GAD antibodies.
Method
In two patients with CCE, screening for the presence of anti-GAD and other antibodies was performed, along with a complete workup for alternative diagnoses.
Results
Two patients showing clinical and radiological features of CCE were tested positive for anti-GAD antibodies. MRI scan revealed multiple bilateral areas of cortico-subcortical FLAIR hyperintensities. They were both tested negative for anti-MOG, anti-NMDAr, and anti-GABAAR antibodies. An ovarian teratoma was discovered in patient 1. Clinical and radiological evolution was favorable in both patients after cumulated therapies in the acute phase.
Discussion
CCE could be a new manifestation of anti-GAD antibodies, with distinct features compared to anti-MOG antibodies related to CCE. We recommend screening for anti-GAD antibodies in the context of CCE, especially in case of atypical features for MOG antibodies-associated disease (MOGAD).
期刊介绍:
The European Journal of Neurology is the official journal of the European Academy of Neurology and covers all areas of clinical and basic research in neurology, including pre-clinical research of immediate translational value for new potential treatments. Emphasis is placed on major diseases of large clinical and socio-economic importance (dementia, stroke, epilepsy, headache, multiple sclerosis, movement disorders, and infectious diseases).